UK markets closed

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.00+0.16 (+2.74%)
At close: 03:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
30,058
30,058
0
10
50
Operating expenses
Research development
38,396
38,396
32,636
30,378
24,330
Selling general and administrative
21,661
21,661
17,480
19,017
14,271
Total operating expenses
56,836
56,836
46,703
52,588
36,478
Operating income or loss
-26,778
-26,778
-46,703
-52,578
-36,428
Interest expense
7,982
7,982
5,837
671
333
Total other income/expenses net
-6,322
-6,322
2,106
6,238
-1,593
Income before tax
-39,580
-39,580
-57,033
-46,998
-33,581
Income tax expense
120
120
10
5
9
Income from continuing operations
-39,700
-39,700
-57,043
-47,003
-33,590
Net income
-39,700
-39,700
-57,041
-47,003
-33,590
Net income available to common shareholders
-39,700
-39,700
-57,041
-47,003
-33,590
Basic EPS
-1.68
-1.08
-1.64
-1.35
-1.38
Diluted EPS
-1.68
-1.08
-1.64
-1.35
-1.38
Basic average shares
34,924
36,928
34,781
34,733
24,386
Diluted average shares
34,924
36,928
34,781
34,733
24,386